BioMérieux S.A. BioMérieux S.A.

BioMérieux S.A.

BIM

Pozycja w akcjach #1761
bioMérieux S.A. is a global entity operating across the Americas, Europe, the... bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
Cena akcji
$103.91
Kapitalizacja rynkowa
$12.23B
Zmiana (1 dzień)
0.86%
Zmiana (1 rok)
-19.74%
Kraj
FR
Handel BioMérieux S.A. (BIM)

Kategoria

Healthcare
Wskaźnik P/B dla BioMérieux S.A. (BIM)
Wskaźnik P/B na dzień October 2026 TTM: 2.35
Według najnowszych raportów finansowych i ceny akcji BioMérieux S.A., obecny wskaźnik P/B (TTM) wynosi 2.35. Na koniec 2023 wynosił 3.17.
Historia wskaźnika P/B dla BioMérieux S.A. od 2005 do 2026
Wskaźnik P/B na koniec każdego roku
Rok Wskaźnik P/B Zmień
2026 (TTM) 2.35 -19.06%
2024 2.90 -8.42%
2023 3.17 -1.23%
2022 3.20 -32.49%
2021 4.75 -15.37%
2020 5.61 31.67%
2019 4.26 21.25%
2018 3.51 -30.21%
2017 5.03 45.96%
2016 3.45 18.84%
2015 2.90 18.48%
2014 2.45 2.52%
2013 2.39 0.46%
2012 2.38 19.55%
2011 1.99 -33.65%
2010 3.00 -25.42%
2009 4.02 16.27%
2008 3.46 -33.46%
2007 5.20 42.01%
2006 3.66 3.63%
2005 3.53 0.00%
Wskaźnik P/B dla podobnych firm lub konkurentów
Firma Wskaźnik P/B Różnica wskaźnika P/B Kraj
4.7411 101.98%
US
3.0143 28.42%
US
31.051 1,222.84%
US
- -
CN
6.6641 183.90%
US